Skip to main content
Clinical Trials/NCT01058746
NCT01058746
Completed
N/A

A Prospective Randomized Controlled Clinical Trial of Restrictive Versus Liberal Perioperative Fluid Management for Patients Undergoing Pancreatic Resection

Memorial Sloan Kettering Cancer Center1 site in 1 country331 target enrollmentJanuary 2010

Overview

Phase
N/A
Intervention
Not specified
Conditions
Pancreatic Cancer
Sponsor
Memorial Sloan Kettering Cancer Center
Enrollment
331
Locations
1
Primary Endpoint
To determine if restrictive perioperative fluid management results in fewer complications, morbidity and decreased length of stay in patients undergoing pancreatic resection, compared to liberal fluid management.
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

The purpose of this study is to help us learn what the best amount of fluid is that patients should receive during pancreas surgery. Patients will receive either the liberal fluid amount for this surgery or a restricted fluid amount.

Both amounts of fluid have been used safely in patients having similar surgeries. These amounts have not been compared in pancreatic surgery. The fluids regimens that will be given are not experimental.

This study will compare patients in the liberal and restricted fluid groups in terms of the nature of any surgical complications (problems)and recovery from surgery, including length of hospital stay.

Registry
clinicaltrials.gov
Start Date
January 2010
End Date
September 2019
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adults \> or = 18 years
  • Patients scheduled for Pancreaticoduodenectomy, Central Pancreatectomy or Distal Pancreatectomy.

Exclusion Criteria

  • Pregnancy
  • History of active coronary disease unless a cardiac stress test showing no reversible ischemia and normal LV function within 30 days of operation
  • MI within 3 months
  • History of stroke
  • History of congestive heart failure and ejection fraction less than 35%
  • History of severe COPD and resting oxygen saturation (SpO2) \< 90%
  • Renal dysfunction (Cr \> 1.8)
  • Abnormal coagulation parameters (INR \> 1.5 not on Coumadin, or platelet
  • Presence of active infection including HIV
  • BMI \> 35

Outcomes

Primary Outcomes

To determine if restrictive perioperative fluid management results in fewer complications, morbidity and decreased length of stay in patients undergoing pancreatic resection, compared to liberal fluid management.

Time Frame: 3 years

Secondary Outcomes

  • Determine if restrictive perioperative fluid management, comp to liberal periop fluid management, decreases delayed gastric emptying, length of stay (LOS) & the incidence of other, less frequent morbidity in adult patients getting pancreatic resection.(3 years)

Study Sites (1)

Loading locations...

Similar Trials